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Rapport de synthèse 
« Faible prévalence de la fibrillation auriculaire chez des adultes 
asymptomatiques à Genève, Suisse » 
But: l'augmentation de la prévalence de la fibrillation auriculaire (FA) est dans les 
pays développés un problème de santé publique. L'ampleur de cette augmentation 
demeure cependant peu claire. L'objectif de ce travail est de déterminer la 
prévalence de la FA au sein d'un échantillon représentatif d'adultes 
asymptomatiques de plus de 50 ans. 
Méthode: entre janvier 2005 et décembre 2007, des individus résidants du canton 
de Genève et ayant déjà participé précédemment à une étude randomisée ont été 
invités pour un examen de contrôle. Le diagnostic de FA a été posé à l'aide d'un 
tracé électrocardiographique 6 pistes. Tous les tracés ont étés revus par un 
cardiologue. Les prévalences de FA ont ensuite été standardisées pour la distribution 
d'âge dans la population genevoise. Une prise de sang veineuse a été réalisée chez 
tous les participants après 8 heures de jeûne et la glycémie, la triglyceridémie, le 
cholestérol sérique total ainsi que le cholestérol HDL sérique ont été déterminés. 
Résultats : la participation a été de 72.8%. 29 cas de FA (22 hommes) ont été 
diagnostiqués parmi 3285 sujets (1696 hommes). La prévalence de la FA (95% Cl) 
était de 0.88% (0.86, 0.90). La prévalence standardisée pour l'âge était légèrement 
plus élevée [0.94% (0.91, 0.97), hommes: 1.23% (1.19, 1.27), femmes: 0.54% (0.47, 
0.61 )]. Les sujets avec une FA étaient plus âgés (72.1 vs. 63.1 ans, p < 0.0001 ), plus 
souvent de sexe masculin (75.9% vs. 50.4%, p = 0.0087), avaient un indice de 
masse corporelle plus élevé (27.9 vs. 25,9 kg/m 2 , p = 0.011), un périmètre abdominal 
plus important (98.8 vs. 90.2 cm, p = 0.0034), une tension artérielle diastolique plus 
élevée (80.9 vs. 75.7mmhg, p = 0.0093), un cholestérol sérique total plus bas (5.16 
vs. 5.75mmol/L, p = 0.0019) et un HDL cholestérol sérique plus bas (1.31 vs. 1.48 
mmol/L, p = 0.02). A l'anamnèse un antécédent« d'embolie artérielle » (cérébrale ou 
membres inferieurs) était significativement plus fréquent chez les sujets avec une FA 
(10.3 vs. 3.3%, p = 0.03). 
Conclusion : cette étude basée sur une population suisse asymptomatique montre 
une prévalence de la FA inférieure à 1 %. Ces résultats sont moins alarmants que 
ceux obtenus lors de précédentes études. 
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To determine the prevalence of atrial fibrillation (AF) in a population-based sample of adults. 
Between january 2005 and December 2007 individuals aged :::sa years, residents of the city of Geneva, who had 
participated in a previous random survey were invited for follow-up examination. AF was assessed on a single 
resting 6-lead ECG. Reported prevalences were standardized for the age distribution of Canton Geneva. Overall par-
ticipation was 72.8%. Twenty-nine cases of AF (22 men) were diagnosed among 3285 subjects (1696 men). The crude 
prevalence of AF (95% Cl) was 0.88% (0.86, 0.90) overall, but higher in men [1.30% (1.26, 1.34)] than in women 
[0.44% (0.41, 0.47)]. The age-standardized AF prevalence was slightly higher [overall: 0.94% (0.91, 0.97), men: 
1.23% (1.19, 1.27), women: 0.54% (0.47, 0.61)]. AF prevalence increased with age in both sexes. A 'history of 
suspected arterial embolism' (brain or legs) was higher in the AF cases (10.3 vs. 3.3%; P = 0.03). 
This population-based survey of a general Swiss population indicates that the prevalence of AF remains below 1%. 
These results are less alarming than those from previous studies based on patients seeking medical care. 
Atrial fibrillation • Crude overall prevalence • Age-standardized prevalence • Check-up 
The increasing prevalence of atrial fibrillation (AF), the most 
common sustained arrhythmia in western countries, is a public 
health concern 1- 3 because it is associated with an increased risk 
of death,4 congestive heart fallure, and embolie events, including 
stroke.3 The aim of this study was (i) to estimate the prevalence 
of AF in a population-based sample of adults aged 50 years 
or more and, (ii) to determine whether AF is associated with 
hypertension or a history of cardiovascular disease. 
Between 1stjanuary 2005 and 31st December 2007 men and women 
aged 50 years or more who were residents of the city and canton of 
Geneva, Switzerland and had participated in a previous random 
survey of the Geneva adult population aged 35-74 years were 
invited for follow-up examination. The ongoing, community-based sur-
veillance project Bus Santé ('Health Bus') has been continuously moni-
toring chronic disease risk factors in the resident adult population of 
the canton of Geneva, Switzerland since 1993.5 The canton of 
Geneva (246 km2) has a population of ,..,438 500 primarily French-
speaking inhabitants, of whom 61% are of Swiss and 39% of foreign 
origin. Of the latter approximately three-fourths are of European 
origin and just over one-half corne from Mediterranean countries, 
namely Spain, France, ltaly, and Portugal. Survey participants were 
selected independently and uniformly throughout each year since 
1993 to represent the "'218 000 non-institutionalized men and 
women aged 35-74 years residing in the canton. Eligible subjects 
are identified using a standardized procedure from an annual residen-
tial database established, maintained and constantly updated by the 
cantonal government. AU Swiss and foreign citizens living in the 
canton with an official residence permit are registered. The only 
specific information from the list used in the survey (gender, age, 
and Swiss or foreign origin) is highly accurate. Stratified randorn 
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sampling by gender within 10-year age strata is proportional to the 
corresponding population distributions. Selected subjects are mailed 
an invitation to participate and, if they do not respond, up to seven tel-
ephone attempts at different times on various days of the week are 
made. If telephone contact is unsuccessful, two more letters are 
mailed. Each subject's recruitment lasts from 2 weeks to 2 months. 
Subjects who are not reached (15% of men, 19% of women) are 
replaced using the same selection protocol. Previous results have 
shown that such subjects usually no longer reside in the canton, so 
are not eligible for the study. Subjects who refuse to participate are 
not replaced. Participating subjects are not eligible in future surveys. 
Annual participation rates have ranged from 57 to 65%. 
Recruitment for the follow-up visit was done by mail and telephone 
(up to five times). Subjects who could not be reached after this inten-
sive recruitment process were not replaced. Overall participation was 
72.8% (71.5% in men and 74.2% in women). 
Participating subjects were invited to corne to a mobile health unit 
(the Bus Santé) located alternatively during the week at three different 
fixed locations in Geneva. At the time of their appointment, subjects 
returned their completed self-administered questionnaires (previously 
sent by mail) on general health, diet, and physical activity. The health 
questionnaire requested, inter alia, information on the subject's 
medical history of myocardial infarction, angina pectoris, 'history of 
suspected arterial embolism', diabetes mellitus, hypertension, hyperch-
olesterolemia, and their treatment. T rained technicians checked the 
questionnaires for correct completion and performed anthropometric 
(weight, height, and waist circumference) as well as clinicat (ECG, 
venous blood sample, and blood pressure) measurements. Ali partici-
pants gave written informed consent for their inclusion in the study. 
The surveys were approved by the ethical committee for epidemiolo-
gical research and public health, lnstitute for Social and Preventive 
medicine at the University of Geneva. 
A resting 6-lead body surface ECG (derivations: I, Il, Ill, AVF, AVL, AVR) 
was recorded using a portable ECG machine (Schiller Reomed® AG, 
Dietikon, Switzerland). The recordings were performed in a sitting 
position at a paper speed of 25 mm/s. Data on basic rhythm, ventricu-
lar rate, P waves, PQ interval, QRS width, and QT interval were col-
lected and a cardiologist reviewed ail recordings. AF was defined by 
the absence of P waves, by the presence of an irregular atrial activity 
between 350 and 600 per minute, and by the presence of an irregular 
ventricular response. Atrial flutter was defined by the absence of P 
waves and the presence of regular f waves with an atrial activity 
between 250 and 350 per minutes. 
A venous blood sample was taken from each study participant after an 
8 h fasting period. Analyses were performed in the Lipid Laboratory, 
Clinicat Diabetes Unit, Geneva University Hospitals. Measurements 
included glycemia (colorimetric enzymatic assay, Labodia®, 
Switzerland), triglyceridemia (Randox Laboratories® Ltd., Crumlin, 
UK), total cholesterolemia (Randox Laboratories® Ltd., Crumlin, UK) 
and HDL cholesterolemia (Randox Laboratories® Ltd., Crumlin, UK). 
Blood pressure was measured using an oscillometer (Omron® HEM 
907), which was calibrated every 12 months with a standard sphygmo-
manometer. The standardized measurements were performed with 
the study participant seated after a 10 min rest, and were repeated 
three successive times at 1-min intervals. For analyses the mean of 
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the first and second measurements were calculated, however, if the 
difference was larger than 10 mmHg, the mean of the two closest 
values was calculated. 
Comparisons between the characteristics of the subgroups of study 
participants (i) free of AF (Non-AF) vs. (ii) those diagnosed with AF 
(AF cases) were made with independent sample Student's t-tests for 
continuous variables and by J tests for categorical variables. Atrial 
flutters were not included in the AF cases. 
Overall and sex-specific crude (unadjusted) and age-adjusted preva-
lence of AF were estimated using the large sample normal theory 
approximation to the Poisson distribution.6 The age-adjustment 
involved estimating the age-subgroup·specific expected numbers of 
AF cases and weighting by the sample vs. population age subgroup 
sizes. These AF prevalences were also estimated with approximate 
95% percent confidence intervals (95% Cl). 
A total of 3285 participating study subjects (1696 men and 1589 
women) who had at least reached their 50th birthday in 2005-
07 were investigated. The overall mean (SD) age was 63.2 (8.6) 
years. There were in total 29 cases of AF comprising 22 men 
and 7 women identified during the 3-year study period. There 
was only 1 case of atrial flutter (typical atrial flutter). 
Characteristics of the two subgroups (i) free of AF (Non-AF, 
n = 3256) and (ii) those diagnosed with AF (AF cases, n = 29) 
are presented in Table 1. On average, the AF cases were signifi-
cantly older (72.1 vs. 63.1 years, P < 0.0001); showed a significant 
male predominance (75.9 vs. 50.4%, P = 0.0087); had a significantly 
higher body mass index (body mass index 27.9 vs. 25.9 kg/m2, P = 
0.011) and had a larger waist circumference (98.8 vs. 90.2 cm, P = 
0.0034). AF subjects also had a significantly higher diastolic blood 
pressure (80.9 vs. 75.7 mmHg, P = 0.0093); a significantly lower 
total serum cholesterol (5.16 vs. 5.75 mmol/L, P = 0.0019) and a 
lower high-density lipoprotein (HDL) cholesterol (1.31 vs. 
1.48 mmol/L, P = 0.02). 
The crude overall prevalence of AF (95% Cl) was 0.88% (0.86, 0.90) 
(Figure 1). The crude prevalence of AFwas higher in men [1.30% (1.26, 
1.34)] than in women [0.44% (0.41, 0.47)]. The corresponding 
age-adjusted AF overall prevalence was slightly higher [0.94% (0.91, 
0.97)] than the overall AF crude prevalence. The corresponding 
age-adjusted prevalence of AF for men was slightly lower [1.23% 
(1.19, 1.27)] than their crude AF prevalence, but the age-adjusted 
AF prevalence for women was slightly higher [0.54% (0.47, 0.61)] 
than their AF crude prevalence. AF prevalence was higher in older 
age groups in both sexes (Figure 1). lndeed, the crude AF prevalence 
is nearly triple among study participants aged 70 years or more 
(Figure 1), among whom over two thirds of the AF cases were ident-
ified overall and in both sexes, compared with the corresponding AF 
prevalence among study participants aged 50 years or more. 
ln patients with AF, the overall mean (SD) rate of ventricular 
response was 79.2 (14.6) beats per minute (range 54-135). 
Among the 29 cases of AF, eight (28%; seven men and one 
woman) were previously known to their attending physician. 
11' 
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Characteristics of the subgroups of study participants free of atrial fibrillation vs. th ose diagnosed with atrial 
fibrillation, Geneva, Switzerland, 2005-07 
Characteristics Non-AF cases (n = 3,2S6t AF cases (n = 29) P-valueb 
Age (years) 63.1 (8.6)' 72.1 (7.0) <0.0001 
Sex (%men) 50.4d 75.9 0.0087 
Body mass index {kg/m2) 25.9 (4.1) 27.9 (3.4) 0.011 
Waist circumference (cm) 90.2 (15.7) 98.8 (10.2) 0.0034 
Systolic blood pressure (SBP, mmHg) 132.8 (18.7) 135.0 (20.7) 0.53 
Diastolic blood pressure (DBP, mmHg) 75.7 (10.6) 80.9 (12.9) 0.0093 
Total serum cholesterol (mmol/L) 5.75 (1.01) 5.16 (1.04) 0.0019 
High density lipoprotein cholesterol (mmol/L) 1.48 (0.39) 1.31 (0.32) 0.020 
Triglycerides (mmol/L) 1.30 (0.79) 1.34 (.74) 0.80 
Blood glucose (mmol/L) 5.32 (1.20) 5.62 (1.24) 0.19 
History of myocardial infarction (%) 3.4 3.6 0.97 
History of angina pectoris (%) 3.4 3.4 0.99 
History of suspected arterial embolism (%) 3.3 10.7 0.032 
Current smoker (%) 3.8 10.3 0.46 
Ex-smoker (%) 43.6 34.5 (2 df) 
Cholesterol treatment (%) 21.6 24.1 0.74 
Hypertension treatment {%) 26.5 44.8 0.026 
Diabetes treatment (%) 4.6 20.7 <0.0001 
'Excludes AF cases, blndependent sample Student's t-test for continuous variables;/ test (1 degree of freedom unless noted otherwise) for categorlcal variables, 'Mean (SD) for 
contlnuous variables, dPercentage for categorical variables; Bold: P < 0.05. AF, atrial fibrillation; df, degree of freedom. 
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Review of published reports on prevalence of atrial fibrillation 
Authors Place Sample (n) Year AF diagnosis Age (years) %ofwomen Prevalence (%) 
Majeed et al 1 England & Wales, UK 211 practitioners (n = 1.4 millions) 1998 Medical records AU ages Unknown OveraU; m 1.2; w 1.3 
0-34; m 0.1; w 0.1 
35-44; m 0.3; w 0.2 
45-54; m 0.7; w 0.4 
55-64; m 1.8; w 1.1 
65-74; m 4.6; w 3.3 
75-84; m 9.1; w 7.2 
2'.;85; m 10.6; w 10.9 
Wolf et al3 Framingham (MA), USA Ali inhabitants invited (n = 5070) 1948-82 Medical files, ECG/2 years 50-89 Unknown 50-59; 0.5 
60-69; 1.8 
70-79;4.8 
80-89; 8.8 
Ônundarson et al.11 Reykjavik, Island All inhabitants invited (n = 9067) 1968-71 ECG 32-64 52 OveraU; m 0.41 ; w 0.15 
Heeringa et al. 12 Rotterdam, NL All inhabitants invited (n = 6808) 1993-94 Single ECG :::ss 59 Overal~ 5.5 
55-59; m 0.8; w 0.6 
60-64; m 2.6; w 1.0 
65-69; m 5.2; w 29 
70-74; m 6.9; w 5.4 
75-79; m 13.0; w 6.5 
80-84; m 15.2; w 12.7 
2'.;85; m 17.9; w 17.5 
Lake et al 13 Busselton, Australia AU inhabitants invited (n = 1770) 1966-81 ECG/3 years >60 48 Overal~ 1.5 
60-64; m 1.1; w 23 
65-69; m 3.3; w 27 
70-74; m 8.6; w 5.5 
:::75; m 15.0; w 8.4 
Langenberg et al 17 Netherlands 10 practitioners (n = 40 185) 1996 Medical file, ECG if irregular pulse 2'.;60 Unknown Overal~ 5.1 
60-69; m 3.3; w 2.3 
70-79; m 7.0; w 6.3 
2:80; m 12.1; w 8.7 ~ 
Furberg et al. 18 Four communities, USA Medicare recipients (n = 5201) 1993 Single ECG 2:65 57 Overal~ m 6.2; w 4.8 (/) (') 
::;,-
Anamnesis 65-69; m 5.9; w 28 3 
c 
70-79; m 5.8; w 5.9 i::l' 
>80; m 8.0; w 6.7 ~ ~ 
Wheeldon et aL 19 Sheffield, UK Four practitioners (n = 1207) 1998 Single ECG ?:65 
Nakayama et aL 26 Shibata, Japan AU inhabitants invited (n = 2651) 1997 Single ECG ?:40 
Labrador Garcia et aL 27 Toledo, Spain AU inhabitants invited (n = 1206) 1998 Single ECG ?:65 
Anamnesis 
Sudlow et al. 28 Northumberland, UK 26 practitioners (n = 4843) 1998 Single ECG ?:65 
Gehring et aL 29 Germany Random sample (n = 4003) 1984-85 Single ECG 25-64 
Hobbs et aL 30 West Midlands, UK 50 health centers (n = 14 781) 2005 Medical file ?:65 
Unknown Overal~ 5.4 
65-69; 2.3 
70-74; 4-1 
75-79; 5.8 
80-84; 6.4 
?:85; 8.1 
58 OveraU; 1.3 
55 Overal~ m 4.5; w 6.4 
65-74; m 3.1; w 4.6 
75-84; m 8.5; w 7.2 
?:85; m 4.5; w 27.3 
Unknown ?:65; 4.7 
::::75; m 10; w 5.6 
50 Overal~ m 0.2; w 0.3 
25-44; m 0.0; w 0.0 
45-54; m 0.2; w 0.0 
55-64; m 0.9; w 1.4 
57 Overal~ 7.2 
65-69; m 3.0; w 1.7 
70-74; m 5.0; w 3.4 
75-79; m 7.3; w 5.0 
80-84; m 10.3; w 7.2 
::::SS; m 11.1; w 9.1 
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A 'history of suspected arterial embolism' involving brain or legs was 
significantly higher in the AF cases compared with the non-AF sub-
jects (10.7 vs. 3.3%, P = 0.032) (Table 1). There were no significant 
differences for either history of myocardial infarction or angina pec-
toris between the latter two subgroups (range 3.4-3.6%, Table 1). 
This population-based survey of a European population found a 
lower prevalence of AF in subjects aged 50 years or more than 
in most other studies, with an overall prevalence of 0.9%. The 
overall AF prevalence for all age classes has been estimated in 
the literature to be between 0.2 and 1.2%.1•7•8 - 11 For populations 
over 50 years of age this figure is much higher, between 1.5 and 
5.5%.2·3•12•13 Table 2 shows comparative data on the estimated 
AF prevalence rates reported in other studies. The very high 
density of primary care physicians and cardiologists in the canton 
of Geneva leads possibly to a broader screening and treatment 
of AF risk factors, what might explain the low prevalence in the 
present study. 
The studies in Table 2 are not strictly comparable because of 
their design heterogeneity. Prevalence varies according to the 
sex, age or ethnicity distributions of patients. Methods of diagnos-
ing AF (e.g. single ECG, multiple ECG distributed in time, history 
with the patient, medical records review or a combination of 
these parameters) also influence the results of the survey. A 
study based on biennial electrocardiographic recordings and on a 
systematic medical record review3 may miss less intermittent AF. 
AF seems to have a lower prevalence in Afro-Americans than in 
Caucasians.14.15 Two other studies based on a single electrocardio-
gram within the framework of a free and voluntary screening 
among asymptomatic people also showed a low AF prevalence. 
Jeong9 in a study conducted in patients more than 40 years of 
age reported a AF prevalence of 1.2% for men and of 0.4% for 
women. Guize et al. 8 reported in patients older than 30 years of 
age values of 0.24 and 0.11 % for men and women, respectively. 
Finally, an additional cause of heterogeneity across studies is 
related to the context: AF prevalence is considerably higher in hos-
pitalized patients as shown by Patel16 reporting an AF prevalence 
of 22% in an elderly hospitalized population. 
The general characteristics of AF prevalence in this random 
population-based survey are similar to those found in other 
studies. First, the AF prevalence is higher in men,1•2•7•9•10•12•17•18 
even after adjustment for the co-morbidities.4 The reason for 
this difference remains unclear. Despite a higher prevalence in 
men, the absolute number of women with AF is more important 
because of their longer life expectancy.10 Second, the incidence 
of AF increases with age both in men and in women.2·3·9•10·12·13•17·1 9 
AF prevalence is increasing ail over the world.1- 3 This increase 
is probably due to aging of the populations and possibly related to 
an increase in risk factor exposures. For example, an increase in 
the prevalence of ischemic heart disease20- 23 could contribute 
to an increase in AF prevalence. ln our survey a 'history of sus-
pected arterial embolism' (involving brain or legs) was significantly 
higher in the AF cases compared with the non-AF subjects but a 
M. Schmutz et al. 
history of myocardial infarction or angina did not differ between 
the two groups, suggesting that 'arterial embolism' may be a con-
sequence of AF rather than a predisposing factor for AF. 
There are some limitations in this study. (i) A selection bias can 
explain the relatively low AF prevalence in our study. lt is difficult 
to compare characteristics of our regional populations with those 
of the general Swiss population. However, the MONICA study of 
the cantons of Fribourg and Vaud24 (population of 784 000 in habi-
tants) between 1992 and 1993 in subjects aged 55-75 yielded a 
mean body mass index in men of 27.3 kg/m2 and in women of 
26.7 kg/m2; a mean systolic blood pressure in men of 
143.9 mmHg and in women of 138.9 mmHg; a mean diastolic 
blood pressure in men of 85.5 mmHg and in women of 
80.8 mmHg; a mean total serum cholesterol level in men 
6.38 mmol/L and in women of 6.8 mmol/L; a proportion of 
active smokers in men of 20.2% and in women of 13.7%. When 
compared with values in Table 1, even if the age distribution is 
not exactly the same, it seems that mean body mass index, 
blood pressure (systolic and diastolic) and mean total serum 
cholesterol level are less elevated and that there are clearly less 
active smokers in our population. For diabetes mellitus a similar 
study conducted in the city of Lausanne (canton of Vaud)25 in 
2006 among subjects aged 35-75 showed an impaired fasting 
glucose prevalence of 25% and a diabetes mellitus prevalence of 
7%. Thus it seems that our population is less exposed to traditional 
cardiovascular risk factors and resulting AF risk factors (hyperten-
sive heart disease, coronary heart disease, cardiac failure). We 
cannot rule out that patients already followed medically for AF 
or patients too sick because of the invalidating effects of AF 
chose not to participate in this survey. (ii) The sample was based 
on a follow-up of a population-based, representative sample of 
the Geneva adult population. Losses to follow-up may have com-
promised its representativeness. There is, however, no reason to 
consider that AF perse would have constituted an obstacle to par-
ticipate in the follow-up, especially among people familiar with the 
survey. Moreover, standardizing prevalence of AF on the age distri-
bution of the target population compensated for random imbal-
ances on the sample age distribution resulting from the 27% 
non-participation. (iii) The probability of underestimation of the 
AF prevalence using a single electrocardiogram should be taken 
into account when comparing AF prevalence rates reported by 
other studies. For example, Furberg et al. 18 found that 50% of 
the diagnosed AF cases were missed on a single ECG and were 
only diagnosed after accounting for the patient history. 
We wish to thank ail Bus Santé technicians for their valuable work 
and Dr James of the Diabetology laboratory of the University Hos-
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